Log In
Print
BCIQ
Print
Print this Print this
 

Emend, Proemend, aprepitant (MK-0869, MK-869) (formerly ONO-7436)

Also known as: formerly L-754030

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionSelective neurokinin1 (NK1) receptor antagonist
Molecular Target Neurokinin 1 (NK1) Substance P receptor (TACR1)
Mechanism of ActionNeurokinin-1 (NK-1) (Substance P) receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today